Last Posted: Sep 29, 2021
- Variants of MIRNA146A rs2910164 and MIRNA499 rs3746444 are associated with the development of cutaneous leishmaniasis caused by Leishmania guyanensis and with plasma chemokine IL-8.
de Mesquita Tirza Gabrielle Ramos, et al. PLoS neglected tropical diseases 2021 9 (9) e0009795
- The role of cytotoxic T-Lymphocyte antigen-4+49A/G gene polymorphism in cutaneous leishmaniasis.
Al-Ghabban Mohammed J S, et al. Microbial pathogenesis 2021 6 105073
- Interleukine-22 gene variants are associated with susceptibility to visceral leishmaniasis.
Kalani Mehdi, et al. Experimental parasitology 2021 6 108122
- TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis.
Mandal Abhishek, et al. Innate immunity 2021 4 1753425920965658
- Genetic variations in the human immune system influence susceptibility to tegumentary leishmaniasis: a systematic review and meta-analysis.
Lera-Nonose Daniele Stéfanie Sara Lopes, et al. Expert review of clinical immunology 2021 3
- Role of IL-17 gene polymorphism in Indian kala-azar.
Khatonier R, et al. Journal of vector borne diseases 0 0 (1) 23-30
- Temporal analysis of visceral leishmaniasis between 2000 and 2019 in Ardabil Province, Iran: A time-series study using ARIMA model.
Rahmanian Vahid et al. Journal of family medicine and primary care 2021 9(12) 6061-6067
- Meta-analysis of -308G > A polymorphism in TNFa gene and susceptibility to leishmaniasis.
Ejghal Rajaâ, et al. Cytokine 2021 1 155437
- Association of cytokine gene polymorphisms with susceptibility to cutaneous leishmaniasis in a Turkish population.
Kirik Fatma Esin, et al. Parasite immunology 2020 7 e12775
- Primary Immunodeficiencies in a Mesoregion of São Paulo, Brazil: Epidemiologic, Clinical, and Geospatial Approach.
Boton Pereira Denise Helena et al. Frontiers in immunology 2020 11862
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.